ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sienna Biopharmaceuticals Appoints Erle Mast, Former CFO and Co-Founder of Clovis Oncology, to Board
June 15, 2017Sienna Biopharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery... -
Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock
January 05, 2017Clovis Oncology, Inc. (NASDAQ:CLVS) announced today the pricing of an underwritten public offering of 5,000,000 shares of its common stock at $41.00 per share, before underwriting discounts and commissions.
Pharma Sources Insight January 2025
